Artemether Oral Suspension | Artemisine Medicines Technology

Name: Artemether Oral Suspension 15 mg/5 mL
Brand: Artemisine Medicines Technology Co., Ltd.

Suspensions

Artemether Oral Suspension 15 mg/5 mL

● Artemether is a semi-synthetic derivative of artemisinin (qinghaosu) with antimalarial activity estimated at 10–20 times that of artemisinin [2]
● Acts rapidly against the erythrocytic (blood) stages of the malaria parasite: kills schizonts, inhibits parasite growth and reproduction, reduces fever and clears parasites quickly [1][2]
● Effective against chloroquine-resistant falciparum malaria and severe falciparum malaria; not effective against the gametocyte stage [2]
● Oral suspension form is easy to take, has a pleasant taste and is suitable for children, infants and patients who cannot swallow tablets [1]
● Standard specification: 15 mg artemether per 5 ml, 60 ml bottle; shelf life 36 months [1]

Product Name	Artemether Oral Suspension 15 mg/5 mL
Dosage Form	Suspensions
Strength	15 mg/5 mL ， 60 mL
Standards	BP / ENTERPRISE
Packing	Customized per market requirement (bottle / blister / box)
Documents	COA, COPP, DMF, CTD Dossiers
MOQ	Contact us for MOQ and current stock

Request Quotation › ← Back to Suspensions

WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾

● Treatment of uncomplicated Plasmodium falciparum malaria [1] ● Malaria infection in adults, infants and children [1] ● Routine oral antimalarial therapy for mild to moderate malaria [1] ● WHO guidelines strongly recommend artemisinin-based combination therapy (ACT) for uncomplicated P. falciparum malaria in children and adults; monotherapy products should be used according to local treatment guidelines and medical prescription [3]

💧Administration▾

● Shake the bottle well before each use [1] ● Take orally directly; measure the prescribed volume with the dosing device supplied [1] ● The dosage is calculated by age and body weight; follow WHO malaria treatment guidelines or the doctor’s prescription [1] ● Complete the full treatment course as directed to prevent relapse [1][2]

⚖️Dosage▾

Dosing depends on the patient’s age and body weight and should follow WHO malaria treatment guidelines or medical prescription [1]. The reference oral dosing for artemether as a single agent is an initial dose of 160 mg, followed by 80 mg once daily for 4–6 days, with the dose reduced in children [2]. ● Calculate the dose by age and body weight; adjust under medical supervision [1] ● WHO currently recommends ACT (e.g. artemether + lumefantrine) as first-line for uncomplicated P. falciparum malaria — regimen selection should follow national treatment guidelines [3]

⚠️Precautions & Warnings▾

● Prescription medicine — use only under medical guidance [1] ● Contraindicated in patients with hypersensitivity to artemether or other artemisinin derivatives [1] ● WHO recommends artemisinin-based combination therapy for uncomplicated malaria; single-ingredient artemisinin products should be used per local guidelines, and the full course must be completed to prevent recrudescence [1][3] ● Adverse reactions are generally mild: occasional transient low-grade fever, mild elevation of liver transaminases (AST/ALT) and transient decrease in reticulocyte count [2] ● Use with caution in pregnancy and lactation — follow medical advice [1] ● Storage: keep sealed in a cool, dry place, protected from light; do not freeze; use within the recommended period after opening [1] ● Keep out of the reach of children [1] For full prescribing information, refer to the product information / approved prescribing documents of the product concerned [1][2][3].

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Artemether Oral Suspension 15 mg/5 mL — Frequently Asked Questions

Which documents are provided for Artemether Oral Suspension 15 mg/5 mL registration?

Every batch of Artemether Oral Suspension 15 mg/5 mL ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Artemether Oral Suspension 15 mg/5 mL?

MOQ and lead time for Artemether Oral Suspension 15 mg/5 mL depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Artemether Oral Suspension 15 mg/5 mL, subject to the regulatory requirements of the destination market.

Which markets have you exported suspensions products to?

We have supplied suspensions products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Artemether Oral Suspension 15 mg/5 mL controlled?

Artemether Oral Suspension 15 mg/5 mL is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›